Eagle Pharmaceuticals EGRX
$ 2.14
-39.89%
Quarterly report 2023-Q2
added 08-08-2023
Eagle Pharmaceuticals Total Current Liabilities 2011-2024 | EGRX
Annual Total Current Liabilities Eagle Pharmaceuticals
2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
---|---|---|---|---|---|---|---|---|---|---|---|
111 M | 74.4 M | 38.1 M | 38.8 M | 39.7 M | 47.3 M | 41 M | 34.3 M | 22.2 M | - | - | - |
All numbers in USD currency
Indicator range from annual reports
Maximum | Minimum | Average |
---|---|---|
111 M | 22.2 M | 49.6 M |